Physician profile
Natalie Tapaskar
NPI 1477902302
$3,128.60
in general payments reported to CMS, 2019-2025
4 companies · $2,241 in 2025
The $2,241 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $97.04 · 2022: $93.32 · 2023: $698 · 2025: $2,241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,455 · Travel and Lodging: $832 · Food and Beverage: $489 · Education: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,455.00 |
| Travel and Lodging | $831.90 |
| Food and Beverage | $489.45 |
| Education | $161.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $2,187.61 | 2025 | Camzyos |
| Abbott Laboratories | $457.00 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Ensite |
| Abiomed | $386.95 | 2023 | Impella |
| Biotronik INC. | $97.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Tapaskar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.